Trademarkia Logo

Canada

C$
Trademark Search in Canada
Bird Design

View On IC.GC.CA

Bird Design
REGISTERED

on 21 Jun 2010

Last Applicant/ Owned by

Mitsubishi Tanabe Pharma Corporation

2-10, Dosho-machi 3-chomeChuo-ku, Osaka

JP

Serial Number

1357611 filed on 27th Jul 2007

Registration Number

TMA770269 registered on 21st Jun 2010

Registration expiry Date

21st Jun 2035

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

Bird Design

Trademark usage description

chemicals used in photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fir Read More

Vienna Information

3 . 7 . 21

Other birdsAutres oiseaux

3 . 7 . 24

Birds or bats stylized, in shadow or in silhouetteOiseaux ou chauves-souris stylisés, en ombre ou en silhouette

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 11 . 13

Wavy lines or bands, zigzag lines or bandsLignes ou bandes ondulées, en dents de scie

Classification Information

Class [001]
Chemicals used in photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; chemical substances for preserving foodstuffs; chemical products for use in the manufacture of pharmaceuticals, namely amino acids, vitamins and mineral preparations; chemical preparations for use in the manufacture of pharmaceuticals

Classification kind code

12

Class [005]
Pharmaceutical and veterinary preparations, namely angiotensin converting enzyme inhibitor, high-blood pressure, renoparenchymal hypertension, immuno-suppressive, anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for the prevention and treatment of the hypersensitive disorder; pharmaceutical preparations for vascular diseases, namely antiplatelet and serotonin antagonist; pharmaceutical substances, namely, fat emulsion solution for intravenous injection; anti-cancer preparations; anti-allergic preparations; anti-histamine preparations; gammaglobulin preparations; pharmaceutical preparations for the prevention and treatment of renal diseases; pharmaceutical preparations for use in surgical procedures and organ transplantation to prevent reperfusion injuries; amino acids for medical, nutritional or veterinary purposes; vitamins and mineral preparations for medical use; sanitary preparations for medical purposes, namely astringents, disinfectants and antibacterial preparations; food for babies; material for stopping teeth, dental wax; preparations for destroying vermin; fungicides, herbicides; antibiotic and chemotherapeutic medicines; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; immuno-suppressive, anti-inflammatory, antiallergic, hypersensitive and antitoxic medicines; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, ophthalmological and otolaryngological medicines; medicines for cancer

Classification kind code

12

Mark Details

Serial Number

1357611

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 27
on 2th Jun 2009		Approval Notice Sent
Submitted for opposition 67
on 9th Mar 2009		Agent Name Changed
Submitted for opposition 68
on 9th Mar 2009		Rep for Service Name Changed
Submitted for opposition 12
on 26th Nov 2008		Extension of Time
Submitted for opposition 12
on 26th May 2008		Extension of Time
Submitted for opposition 22
on 21st Jan 2008		Search Recorded
Submitted for opposition 20
on 21st Jan 2008		Examiner's First Report
Submitted for opposition 31
on 2th Aug 2007		Formalized
Submitted for opposition 1
on 30th Jul 2007		Created
Submitted for opposition 30
on 27th Jul 2007		Filed